ArticleScientific reports2025
Prognostic nutritional index is a better inflammation based prognostic marker in elderly patients with hepatocellular carcinoma after surgery.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prognostic value of prognostic nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- [The value of the nutritional assessment index or score in prognostic evaluation for patients with liver cancer].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
- Combined Model of Inflammatory-Nutritional Indicators and Tumor Markers for Predicting Prognosis in Patients with Distal Cholangiocarcinoma: A Retrospective Cohort Study.Diseases (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The role of inflammation-related markers in patients with elderly hepatocellular carcinoma (HCC) is not well known. This study aimed to evaluate and compare the prognostic value of various inflammation-related markers in elderly HCC patients after radical resection.350 elderly HCC patients after radical resection were included. Survival rate and prognostic analysis were using Kaplan-Meier and Cox regression analysis. The prognostic value of inflammation-related markers was compared by C-index and time-dependent receiver operating characteristic curve (AUC). Propensity score matching (PSM) was used for patient selection to minimize bias. The C-index and time-dependent AUC showed that PNI was higher than the other inflammation-related markers. After PSM, the 1-year, 3-year, and 5-year overall survival rates in the low prognostic nutritional index (PNI) and high PNI groups were 83.3%, 69.5%, 51.5%, and 95.0%, 87.8%, 71.3% (p = 0.047), respectively. The 1-year, 3-year, and 5-year recurrence-free survival rates in the two groups were 63.3%, 47.8%, 24.5%, and 86.7%, 76.3%, 57.1% (p < 0.001), respectively. Multivariate Cox regression revealed that PNI was the independent risk factor associated with death (p = 0.016, HR = 0.552) and tumor recurrence (p = 0.001, HR = 0.432). PNI was a better inflammation-based prognostic marker in elderly HCC patients after radical resection. This simple marker could help physicians determine elder HCC patients at high risk of tumor recurrence for frequent clinical surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.